Oligonucleotide Synthesis Market USD 2768.9 Million by 2026 at CAGR 6.4% | Valuates Reports

BANGALORE, India, Dec. 10, 2020 /PRNewswire/ -- Oligonucleotide Synthesis Market is Segmented by Type (Custom Oligonucleotides, Pre-designed Oligonucleotides), by End User (Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories, Others), Key Vendors and Regional Growth: Global Opportunity Analysis and Industry Forecast, 2021 - 2026. This report is published on Valuates Reports in the Chemical Industry Category.

The global Oligonucleotide Synthesis market size is projected to reach USD 2768.9 Million by 2026, from USD 1913.7 Million in 2020, at a CAGR of 6.4% during 2021-2026.

Major factors driving the Oligonucleotide Synthesis market size are, increasing demand for innovation in life sciences and medical academia, increasing government investment in genomic technology growth, and increasing demand for oligonucleotide synthesis technologies from public and private research firms.

The report lists the major players in the regions and their respective market share based on global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and leadership changes to stay ahead in the competition. 

Request a Sample Copy of the Report For COVID-19 Impact Analysis on Oligonucleotide Synthesis Market: https://reports.valuates.com/request/sample/QYRE-Othe-4M360/Oligonucleotide_Synthesis_Market

TRENDS INFLUENCING THE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE

Oligonucleotide synthesis is an important part of a variety of ongoing genetic research studies. Rising investments in genetic research are expected to fuel demand for personalized synthesis of different groups of oligos, including decoys, aptamers, immunostimulants, antisenses, siRNAs, and miRNAs. This, in turn, is expected to increase the growth of the Oligonucleotide Synthesis market size. 

Synthetic oligonucleotides also have significant clinical applications, particularly for the detection of autoimmune antibodies. Consistent advances have taken place in synthetic biology over the last few years, where synthetic oligonucleotides have been used to develop tests for the detection of anti-double-stranded DNA. All these factors are expected to drive the oligonucleotide synthesis market size.

View Report Details Before Purchasing : https://reports.valuates.com/market-reports/QYRE-Othe-4M360/oligonucleotide-synthesis 

OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE ANALYSIS

North America is expected to hold the largest Oligonucleotide Synthesis market share during the forecast period. This dominance of North America is attributed to the presence of innovators and key players in the U.S. In addition, North America's strong foothold in genomics, proteomics, oncology, diagnostic screening, and drug development has made a substantial contribution to maintaining its Oligonucleotide share.

Asian countries are regarded as the fastest adopters of sequencing, array technology, and PCR products due to genomics and healthcare studies' rapid progress. Japan and China are perceived to be the most promising markets for expansion and development opportunities. The changing economic scenario, coupled with high investments in health care, life science research programs, and genetics, has also encouraged global players to join the Asia-Pacific market, thus contributing to its growth.

By Region

• North America
• United States
• Canada
• Europe
• Germany
• France
• K.
• Italy
• Russia
• Nordic
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia-Pacific
• Latin America
• Mexico
• Brazil
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Inquire for Regional Data: https://reports.valuates.com/request/regional/QYRE-Othe-4M360/Oligonucleotide_Synthesis_Market

OLIGONUCLEOTIDE SYNTHESIS MARKET SEGMENTATION

by Type, the market is primarily split into

• Custom Oligonucleotides
• Pre-designed Oligonucleotides

by End User, this report covers the following segments

• Academic Research Institutes
• Pharmaceutical and Biotechnology Companies
• Diagnostic Laboratories
• Others

OLIGONUCLEOTIDE SYNTHESIS MARKET KEY PLAYERS

• Integrated DNA Technologies
• Merck
• Eurofins Genomics
• Thermo Fisher Scientific
• Agilent Technologies
• Eurogentec
• GE Healthcare
• LGC Biosearch Technologies
• Nitto Denko Avecia

Buy Now for Single User: https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Othe-4M360&lic=single-user 

Buy Now for Enterprise User: https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Othe-4M360&lic=enterprise-license 

SUBSCRIPTION

We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.

SIMILAR REPORTS : 

- Oligonucleotide Therapeutics Market size is projected to reach USD 7961.1 Million by 2026, from USD 3151.7 Million in 2020, at a CAGR of 16.7% during 2021-2026.

Biogen is the industry's biggest player, with more than 76 percent of 2018 revenue,  followed by Sarepta Therapeutics and Jazz Pharmaceuticals, with 13.35 percent and 6.63 percent, respectively. 

North America and Europe held the largest Oligonucleotide Sales Market share  accounting for more than 80 percent of the combined income.

- Oligonucleotide Pool Market size is projected to reach USD 2559.1 Million by 2026, from USD 1820.5 Million in 2020, at a CAGR of 5.8% during 2021-2026.

The report lists the major players in the regions and their respective market share based on global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition.

- Oligonucleotide Pool Library Market size is projected to reach USD 1740.7 Million by 2026, from USD 1072.9 Million in 2020, at a CAGR of 8.4% during 2021-2026.

- DNA Oligonucleotide Synthesis Market is Segmented by type Primers, Probes, Intermediate-scale Synthesis Oligos, Large-scale Synthesis Oligos, Linkers and Adaptors, by application Commercial, Academic Research and by various regions.

- Oligonucleotide DNA Microarrays (oDNA) Market is Segmented by type Gene expression, Genotyping, Genome cytogenetics, by application Genome cytogenetics Non-invasive pregnancy testing(NIPT), Hypertension, diabetes, Nervous system diseases, Others and by various regions.

- Oligonucleotide Testing Market is Segmented by type Instrument, Software, Service, by application Research, Commercial and by various regions.

To See the List of Related Reports on Oligonucleotide Market

ABOUT US:

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs. 

Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.

To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains detail research methodology employed to generate the report, Please also reach to our sales team to get the complete list of our data sources

CONTACT US:

Valuates Reports
sales@valuates.com
or U.S. Toll-Free Call  +1-(315)-215-3225
For IST Call  +91-8040957137
WhatsApp : +91 9945648335
Website: https://reports.valuates.com
Twitter - https://twitter.com/valuatesreports
Linkedin - https://in.linkedin.com/company/valuatesreports
Facebook - https://www.facebook.com/valuatesreports

Logo: https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg